This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Coherent Biopharma I, Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Xueyuan Xie: Innovator in Multi-Ligand Drug Conjugates
Introduction
Xueyuan Xie is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug conjugates. His work focuses on creating compounds that enhance the delivery of therapeutic agents to target cells.
Latest Patents
Xie holds a patent for "Multi-ligand drug conjugates and uses thereof." This invention involves conjugate compounds or pharmaceutically acceptable salts that comprise a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. The method described in the patent outlines a way to treat diseases by delivering a payload to a subject.
Career Highlights
Throughout his career, Xueyuan Xie has worked with various companies, including Coherent Biopharma I, Limited and Coherent Biopharma. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Xie has collaborated with notable professionals in his field, including Baohua Robert Huang and Jian Dai. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Xueyuan Xie's work in multi-ligand drug conjugates represents a significant advancement in pharmaceutical innovation. His contributions are poised to impact the treatment of various diseases through targeted drug delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile